Refractory Anemia With Excess Blasts: Clinical Trials

3 trials for Refractory Anemia With Excess Blasts, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 terminated. 3 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 23Terminated 3
Phase 11Terminated 1

Follow Refractory Anemia With Excess Blasts: new trials by email Literature Review of Refractory Anemia With Excess Blasts trials Research Report on Refractory Anemia With Excess Blasts

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Decitabine Followed by Idarubicin and Cytarabine in Treating Patients With Relapsed or Refractory AML and MDS
decitabine, idarubicin, cytarabine - Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Monoblastic Leukemia (M5a)
Phase 2TerminatedFred Hutchinson Cancer Center72012-07-012017-03-31
Busulfan, Etoposide, and Intensity-Modulated Radiation Therapy Followed By Donor Stem Cell Transplant in Treating Patients With Advanced Myeloid Cancer
busulfan, etoposide, intensity-modulated radiation therapy - Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities
Phase 1 / Phase 2TerminatedCity of Hope Medical Center252007-06-112023-11-30
Iodine I 131 Monoclonal Antibody BC8, Fludarabine Phosphate, Total Body Irradiation, and Donor Stem Cell Transplant Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients With Advanced Acute Myeloid Leukemia or Myelodysplastic Syndrome
iodine I 131 monoclonal antibody BC8, fludarabine phosphate, total-body irradiation - Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q)
Phase 2TerminatedFred Hutchinson Cancer Center182003-05-012022-12-12

Narrower conditions

Anemia, Refractory, with Excess of Blasts (3)  ·  Congenital Abnormalities (3)  ·  Leukemia, Myeloid, Acute (3)  ·  Blast Crisis (1)  ·  Leukemia, Erythroblastic, Acute (1)  ·  Leukemia, Megakaryoblastic, Acute (1)  ·  Leukemia, Monocytic, Acute (1)  ·  Leukemia, Myelomonocytic, Acute (1)  ·  Leukemia, Myelomonocytic, Chronic (1)

Broader conditions

Anemia (3)  ·  Anemia, Refractory (3)  ·  Bone Marrow Diseases (3)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3)  ·  Hematologic Diseases (3)  ·  Hemic and Lymphatic Diseases (3)  ·  Leukemia (3)  ·  Leukemia, Myeloid (3)  ·  Myelodysplastic Syndromes (3)  ·  Neoplasms (3)  ·  Neoplasms by Histologic Type (3)  ·  Chronic Disease (2)  ·  Disease Attributes (2)  ·  Myeloproliferative Disorders (2)  ·  Pathologic Processes (2)

Interventions

Peripheral Blood Stem Cell Transplantation (2)  ·  Busulfan (1)  ·  Cyclosporine (1)  ·  Cytarabine (1)  ·  Decitabine (1)  ·  Etoposide (1)  ·  Idarubicin (1)  ·  Mycophenolic Acid (1)  ·  Podophyllotoxin (1)  ·  Radiotherapy, Intensity-Modulated (1)  ·  Transplantation (1)  ·  Whole-Body Irradiation (1)  ·  fludarabine phosphate (1)

Sponsors

Fred Hutchinson Cancer Center (2)  ·  City of Hope Medical Center (1)

Countries

United States (3)

Top investigators

Anthony Stein (1)  ·  Derek Stirewalt (1)  ·  Johnnie Orozco (1)

NIH funding

P30CA015704 (2)